Case number 1:20-cv-01585
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 11, 2021 | 29 | SO ORDERED (5) Docket Text: SO ORDERED, re (18 in 1:21-cv-00356-CFC, 28 in 1:20-cv-01153-CFC, 27 in 1:20-cv-01585-CFC) STIPULATION Regarding Consolidation. These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 20-1153-CFC. Signed by Judge Colm F. Connolly on 6/10/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC, 1:21-cv-00356-CFC(nmf) |
| Jun 11, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:20-cv-01153-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 20-1153-CFC ONLY. (nmf) |
| Jun 10, 2021 | 28 | Proposed Order (30) Docket Text: PROPOSED ORDER Stipulated Protective Order by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 8, 2021 | 27 | Stipulation (5) Docket Text: STIPULATION Regarding Consolidation by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jun 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (26 in 1:20-cv-01585-CFC, 27 in 1:20-cv-01153-CFC) Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 10, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 6/2/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Jun 1, 2021 | 26 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 10, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| May 6, 2021 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries Limited's and Sun Pharmaceutical Industries, Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited.(Bilson, David) |
| May 6, 2021 | 25 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Apr 30, 2021 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a) Initial Disclosures filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Apr 22, 2021 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries Limited's and Sun Pharmaceuticals Industries, Inc.'s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited.(Bilson, David) |
| Mar 4, 2021 | 21 | SO ORDERED (4) Docket Text: SO ORDERED, re [20] Stipulation filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Ohm Laboratories, Inc. Party Ohm Laboratories, Inc. terminated. Signed by Judge Colm F. Connolly on 3/4/2021. (fms) |
| Mar 3, 2021 | 20 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Dismissing Defendant Ohm Laboratories, Inc. and Amending Caption by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David) |
| Feb 11, 2021 | 19 | Scheduling Order (20) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 10/28/2022. Expert Discovery due by 6/30/2023. Joint Claim Construction Brief due by 7/21/2022. A Markman Hearing is set for 9/13/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 7/26/2023. A Final Pretrial Conference is set for 8/16/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 9/11/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/11/2021. (nmf) |
| Feb 5, 2021 | 18 | Proposed Order (20) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Feb 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01585-CFC, 18 in 1:20-cv-01153-CFC) STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 5, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 2/4/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Feb 3, 2021 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 5, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharmaceuticals Inc.. (Egan, Brian) |
| Jan 28, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01153-CFC, 16 in 1:20-cv-01585-CFC) STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 3, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 1/28/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Jan 27, 2021 | 16 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to submit a proposed Scheduling Order to February 3, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jan 26, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC.(kmd) |
| Jan 26, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01585-CFC, 1:20-cv-01153-CFC. (kmd) |
| Jan 25, 2021 | 15 | Klein Pro Hac Certification (1) |
| Jan 25, 2021 | 15 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Bryce A. Cooper - filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Klein Pro Hac Certification, # (2) Cooper Pro Hac Certification)(Bilson, David) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Bryce A. Cooper filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Ohm Laboratories, Inc. Signed by Judge Colm F. Connolly on 1/25/2021. (fms) |
| Jan 25, 2021 | 15 | Cooper Pro Hac Certification (1) |
| Jan 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01153-CFC, 14 in 1:20-cv-01585-CFC) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 27, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 1/21/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(fms) |
| Jan 20, 2021 | 14 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 27, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Jan 13, 2021 | 13 | Answer to Counterclaim (10) Docket Text: ANSWER to [11] Answer to Complaint, Counterclaim by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Dec 23, 2020 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Limited for Ohm Laboratories, Inc., Sun Pharmaceutical Industries, Inc. filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Phillips, John) |
| Dec 23, 2020 | 11 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc..(Phillips, John) |
| Dec 17, 2020 | 10 | Order (2) Docket Text: ORDER, on or before January 20, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/20/2021.) Signed by Judge Colm F. Connolly on 12/17/2020. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC(nmf) |
| Dec 2, 2020 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries Limited served on 12/2/2020, answer due 12/23/2020. (Dellinger, Megan) |
| Dec 2, 2020 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries, Inc. served on 12/2/2020, answer due 12/23/2020. (Dellinger, Megan) |
| Dec 2, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Ohm Laboratories, Inc. served on 12/2/2020, answer due 12/23/2020. (Dellinger, Megan) |
| Nov 25, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Nov 24, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) |
| Nov 23, 2020 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3350344.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1, # (2) Civil Cover Sheet)(mal) |
| Nov 23, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. No for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (mal) |
| Nov 23, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2. (mal) |
| Nov 23, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/14/2020. Date of Expiration of Patent: 08/01/2028.Thirty Month Stay Deadline: 4/14/2023. (mal) |
| Nov 23, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Nov 23, 2020 | 1 | Civil Cover Sheet (1) |
| Nov 23, 2020 | 1 | Exhibit 1 (39) |
| Nov 23, 2020 | 1 | Complaint* (1) |
